HIV

Gilead Sciences

Biotech

Gilead settles on twice-yearly treatment partner for lenacapavir

Gilead has chosen which of two assets to pair with lenacapavir moving forward, with plans to share more details on the winner next year.

Darren Incorvaia Oct 30, 2025 6:37pm

Whale swimming in ocean seen from above

Merck wades deeper into HIV PrEP waters with pair of trials

Jul 14, 2025 1:12pm

Signage for the Department of Health and Human Services HHS headquarters is seen on April 02 2025 in Washington DC

Fierce Healthcare

Judge sides with states, blocking HHS reorg and mass layoffs

Jul 1, 2025 3:30pm

Gilead

FDA slaps clinical hold on multiple Gilead HIV trials

Jun 10, 2025 10:48am

investment money shot vaccine pharma dollar

Gilead pays partner Hookipa $10M for HBV, HIV vaccines

May 22, 2025 10:10am

HIV AIDS PREP

GSK posts data on HIV assets vying for roles in 6-month combo

Mar 12, 2025 11:25am